PFIZER INC — Director's Dealing 2018

Feb 28, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2018-02-24

Reporting Person: LUND-JURGENSEN KIRSTEN (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-24	Common Stock	M	15957.0000	$18.9000	Acquired	36959.0000	Direct
2018-02-24	Common Stock	F	3692.0000	$36.2600	Disposed	33267.0000	Direct
2018-02-24	Common Stock	F	5091.0000	$35.9800	Disposed	28176.0000	Direct
2018-02-26	Common Stock	F	896.0000	$37.0900	Disposed	27280.0000	Direct
2018-02-26	Common Stock	S	9510.0000	$37.1900	Disposed	17770.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-24	Stock Appreciation Rights	$18.9000	M	15957.0000	Disposed	2018-02-24	Common Stock (15957.0000)	Direct

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F3: Price is the closing price of Pfizer common stock on February 23, 2018

F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

F6: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).